A. Hinton

A. Hinton's research focuses on cystic fibrosis care, examining how care delivery methods—such as telehealth, in-person, and hybrid visit models—affect patient outcomes like lung function and healthcare utilization. Work also covers medical device safety, including the use of peripherally inserted central catheters (PICC lines) in cystic fibrosis patients, and the impact of newer CF drug therapies (like elexacaftor/tezacaftor/ivacaftor, a combination medication that improves the function of the defective protein causing CF) on long-term care needs. This research is relevant to students interested in clinical outcomes research, healthcare delivery models, and chronic disease management.

Publication activity has been modest but fairly steady over the last five years, with a small increase in output in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026